All News

Immunotherapy and PARP inhibitor combinations may be the future of ovarian cancer treatment, says Samir N. Khleif, M.D.

While Underdog is a made-up cartoon character, "Hysterdog" is the real deal, and so is her love.

A helpful guide for the newly diagnosed.

There's lots of great new research to be excited about but there's still no cure.

Blincyto (blinatumomab) was granted full approval by the Food and Drug Administration (FDA) to treat both children and adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (ALL), regardless of Philadelphia chromosome (Ph) status, according to the developer of the anti-CD19 immunotherapy, Amgen.

A patient's diet may have a great impact on their brain cancer outcomes, according to a recent review.

Abemaciclib was granted a priority review to a new drug application (NDA) to treat patients with advanced hormone receptor (HR)­­–positive, HER2-negative breast cancer, according to Eli Lilly and Company, the manufacturer of the CDK4/6 inhibitor.

Cancer can feel like a ticking time bomb. Here's how one cancer survivor diffused it.

Cancer not only affects the body, it affects the mind as well.

When I returned home from my first visit to my surgeon after my diagnosis of breast cancer, I could see the look of worry on my mother's face.

Children with Philadelphia chromosome-positive chronic phase chronic myeloid leukemia (CP Ph+ CML) may soon have a new treatment

Patients with MPNs face unique challenges with depression and sexual intimacy. Sandra Allen-Bard, BSN, MSN, AOCNP, ANCC, discusses a recent study conducted to better understand these issues.

Adequate protein is essential to meet the increased demands of the body, especially during anti-cancer treatment.

The oncologist has a job unlike any other doctor. Why would anyone want to be an oncologist and what makes them so special? Here is the view of one patient.

After a cancer diagnosis, you need to put your feelings first before anyone else's.

There are many ways to celebrate the absence of cancer.

Pierre Massion, M.D., sat down with CURE to discuss lung cancer screening and prevention.

A study pairs an IDO inhibitor with PD-1 checkpoint blockade.

My wife and I are always amazed at the fond memories and warm feelings that rise up when we return to Nashville.

Three years ago, breast cancer interrupted this survivor's life. Read more to learn how she accepted and embraced that life altering challenge.

Fear of recurrence can motivate good living, but it can also stop you from living.

For women with platinum-sensitive, high-grade ovarian, fallopian tube or primary peritoneal cancer, an improved progression-free survival (PFS) was seen for those who took Rubraca (rucaparib) as a maintenance therapy, compared to placebo, according to the phase 3 ARIEL3 trial.

Strategies from expert oncology dieticians can help patients to eat an appropriate diet and maintain a healthy weight during and after treatment for ovarian cancer.

Sarah Sciortino, MSW, LSW, Oncology Psychosocial Support Services Program Coordinator at University of Chicago Hospital, discusses the unique concerns that younger patients with ovarian cancer can face.

Increasingly, immunotherapy drugs for advanced melanoma are being studied in combination.

An intensive preparatory stem cell transplant (SCT) regimen should be used for younger patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS), according to the results of a phase 3 clinical trial.

For many who have been through the experience, whether you call it a return, recurrence or anything else, it’s something they lay awake at night thinking about, and worrying about.

Summer presents unique challenges for those with lymphedema. Here are some tips to help.

Breast cancer is no holiday.

Blood-based biomarkers are moving into the realm of non-small cell lung cancer (NSCLC), and while tissue biopsies are still the standard, if plasma assays are positive, they can be helpful in deciding the first-line treatment that patients should receive.